Dolby Laboratories, Inc.
NYSE:DLBInformation Technology Services
-$0.10 today
- Market cap
- $5.32B
- Beta
- 0.80
- P/E (TTM)
- 20.0
- EPS (TTM)
- $2.56
- Dividend yield
- 2.76%
Volume 2.61M
Average 0.73M
DLB Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Dolby Laboratories, Inc.NYSE: DLB
Research & Development · Q4 FY2026 · quarter ended Sep 2026
Research & development dips below year-ago levels
Q4 FY2026 research & development of $64.3M fell 4.7% year over year, behind the +0.4% change in trailing-twelve-month research & development. Sequentially, it fell 2.2% from the prior quarter. Over 3 fiscal years it compounded at -1.1% a year.
Context
- Research & development amounted to 18.5% of revenue in FY2026, down 0.9 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -4.7% toward the trailing-twelve-month pace of +0.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 262.78M USD
- Year-over-year change
- +0.4%
- 4-year CAGR
- +0.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-09-25 | 262.78M | +0.4% |
| FY2025 | 2025-09-26 | 261.79M | -0.7% |
| FY2024 | 2024-09-27 | 263.66M | -2.9% |
| FY2023 | 2023-09-29 | 271.52M | +4.0% |
| FY2022 | 2022-09-30 | 261.17M | — |
Research & Development vs competitors
How DLB compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +0.4% is the 5th highest of 7, against a peer median of +2.2%.
- Research & development amounts to 18.5% of revenue for DLB, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $446.07M USD | +3.2% | -1.8% | 21.8% | |
| LTM Sep 2026 | $262.78M USD | +0.4% | -1.1% | 18.5% | |
| LTM Sep 2026 | $155.21M USD | +18.7% | +5.6% | 11.8% | |
| LTM Jun 2026 | $145.06M USD | -5.6% | +7.7% | 23.9% | |
| LTM Jun 2026 | $67.01M USD | +44.9% | +18.5% | 5.6% | |
| LTM Jun 2026 | CN¥32.59M CNY | +1.2% | -3.0% | 0.3% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
INGMIngram Micro Holding Corporation | LTM Jun 2026 | $0 USD | — | — | 0.0% |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding DLB) | — | +2.2% | +5.6% | 0.1% | |
Competitors are the stored peer set for DLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 | FY2026 Sep 2026 |
|---|---|---|---|---|---|
| Revenue | 1.25B | 1.3B | 1.27B | 1.35B | 1.42B |
| Cost of Revenue | 141.36M | 152.57M | 140.5M | 160.13M | 186.5M |
| Gross Profit | 1.11B | 1.15B | 1.13B | 1.19B | 1.23B |
| Gross Margin | 88.7% | 88.3% | 89.0% | 88.1% | 86.9% |
| Research & Development | 261.17M | 271.52M | 263.66M | 261.79M | 262.78M |
| Selling, General & Admin | 634.03M | 612.84M | 604.85M | 647.24M | 651.6M |
| Operating Expenses | 895.21M | 884.36M | 868.52M | 924.04M | 914.38M |
| Depreciation & Amortization | 103.61M | 95.51M | 87.33M | 98.6M | 0 |
| EBITDA | 318.89M | 345.57M | 399.81M | 378.56M | 303.99M |
| EBITDA Margin | 25.4% | 26.6% | 31.4% | 28.1% | 21.4% |
| Operating Income | 217.23M | 262.81M | 264.71M | 264.96M | 303.99M |
| Operating Margin | 17.3% | 20.2% | 20.8% | 19.6% | 21.4% |
| Interest Income | 6.57M | 28.09M | 34.08M | 15.38M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 16.67M |
| Other Income / Expenses | (1.95M) | (12.76M) | 47.77M | 38.53M | 33.39M |
| Income Before Tax | 215.28M | 250.05M | 312.48M | 303.49M | 337.38M |
| Pre-Tax Margin | 17.2% | 19.2% | 24.5% | 22.5% | 23.7% |
| Income Tax Expense | 31.38M | 48.41M | 48.16M | 46.99M | (77.86M) |
| Net Income | 184.09M | 200.66M | 261.83M | 255.02M | 257.74M |
| Net Margin | 14.7% | 15.4% | 20.6% | 18.9% | 18.1% |
| EPS (Basic) | 1.84 | 2.00 | 2.74 | 2.66 | 2.73 |
| EPS (Diluted) | 1.81 | 1.96 | 2.69 | 2.62 | 2.70 |
| Weighted Avg Shares | 99.99M | 95.79M | 95.54M | 95.87M | 94.57M |
| Weighted Avg Shares (Diluted) | 101.98M | 97.59M | 97.33M | 97.48M | 95.59M |
Dolby Laboratories, Inc.
NYSE:DLB
Intrinsic Alpha fair value
Locked
Current Price
$56.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.